Tawseef Dar1,2, Michael T Osborne1,2,3, Shady Abohashem1,2, Taimur Abbasi1,2, Karmel W Choi4,5,6,7, Ahmed Ghoneem1, Nicki Naddaf1, Jordan W Smoller4, Roger K Pitman4, John W Denninger4,5,6,7, Lisa M Shin4,8, Gregory Fricchione4, Ahmed Tawakol1,2,3. 1. Cardiovascular Imaging Research Center (T.D., M.T.O., S.D., T.A., A.G., N.N., A.T.), Massachusetts General Hospital and Harvard Medical School, Boston. 2. Cardiology Division (T.D., M.T.O., S.A., T.A., A.T.), Massachusetts General Hospital and Harvard Medical School, Boston. 3. Department of Medicine (M.T.O., A.T.), Massachusetts General Hospital and Harvard Medical School, Boston. 4. Department of Psychiatry (K.W.C., J.W.S., R.K.P., J.W.D., L.M.S., G.F.), Massachusetts General Hospital and Harvard Medical School, Boston. 5. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA (K.W.C., J.W.S.). 6. Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (K.W.C., J.W.S.). 7. Stanley Center for Psychiatric Research, Broad Institute, Boston, MA (K.W.C., J.W.S.). 8. Department of Psychology, Tufts University, Medford, MA (L.M.S.).
Abstract
BACKGROUND: Chronic exposure to socioeconomic or environmental stressors associates with greater stress-related neurobiological activity (ie, higher amygdalar activity [AmygA]) and higher risk of major adverse cardiovascular events (MACE). However, among individuals exposed to such stressors, it is unknown whether neurobiological resilience (NBResilience, defined as lower AmygA despite stress exposure) lowers MACE risk. We tested the hypotheses that NBResilience protects against MACE, and that it does so through decreased bone marrow activity and arterial inflammation. METHODS: Individuals underwent 18F-fluorodeoxyglucose positron emission tomography/computed tomography; AmygA, bone marrow activity, and arterial inflammation were quantified. Chronic socioeconomic and environmental stressors known to associate with AmygA and MACE (ie, transportation noise exposure, neighborhood median household income, and crime rate) were quantified. Heightened stress exposure was defined as exposure to at least one chronic stressor (ie, the highest tertile of noise exposure or crime or lowest tertile of income). MACE within 5 years of imaging was adjudicated. Relationships were evaluated using linear and Cox regression, Kaplan-Meier survival, and mediation analyses. RESULTS: Of 254 individuals studied (median age [interquartile range]: 57 years [46-67], 36.7% male), 166 were exposed to at least one chronic stressor. Among stress-exposed individuals, 12 experienced MACE over a median follow-up of 3.75 years. Among this group, higher AmygA (ie, lower resilience) associated with higher bone marrow activity (standardized β [95% CI]: 0.192 [0.030-0.353], P=0.020), arterial inflammation (0.203 [0.055-0.351], P=0.007), and MACE risk (standardized hazard ratio [95% CI]: 1.927 [1.370-2.711], P=0.001). The effect of NBResilience on MACE risk was significantly mediated by lower arterial inflammation (P<0.05). CONCLUSIONS: Among individuals who are chronically exposed to socioeconomic or environmental stressors, NBResilience (AmygA <1 SD above the mean) associates with a >50% reduction in MACE risk, potentially via reduced arterial inflammation. These data raise the possibility that enhancing NBResilience may decrease the burden of cardiovascular disease.
BACKGROUND: Chronic exposure to socioeconomic or environmental stressors associates with greater stress-related neurobiological activity (ie, higher amygdalar activity [AmygA]) and higher risk of major adverse cardiovascular events (MACE). However, among individuals exposed to such stressors, it is unknown whether neurobiological resilience (NBResilience, defined as lower AmygA despite stress exposure) lowers MACE risk. We tested the hypotheses that NBResilience protects against MACE, and that it does so through decreased bone marrow activity and arterial inflammation. METHODS: Individuals underwent 18F-fluorodeoxyglucose positron emission tomography/computed tomography; AmygA, bone marrow activity, and arterial inflammation were quantified. Chronic socioeconomic and environmental stressors known to associate with AmygA and MACE (ie, transportation noise exposure, neighborhood median household income, and crime rate) were quantified. Heightened stress exposure was defined as exposure to at least one chronic stressor (ie, the highest tertile of noise exposure or crime or lowest tertile of income). MACE within 5 years of imaging was adjudicated. Relationships were evaluated using linear and Cox regression, Kaplan-Meier survival, and mediation analyses. RESULTS: Of 254 individuals studied (median age [interquartile range]: 57 years [46-67], 36.7% male), 166 were exposed to at least one chronic stressor. Among stress-exposed individuals, 12 experienced MACE over a median follow-up of 3.75 years. Among this group, higher AmygA (ie, lower resilience) associated with higher bone marrow activity (standardized β [95% CI]: 0.192 [0.030-0.353], P=0.020), arterial inflammation (0.203 [0.055-0.351], P=0.007), and MACE risk (standardized hazard ratio [95% CI]: 1.927 [1.370-2.711], P=0.001). The effect of NBResilience on MACE risk was significantly mediated by lower arterial inflammation (P<0.05). CONCLUSIONS: Among individuals who are chronically exposed to socioeconomic or environmental stressors, NBResilience (AmygA <1 SD above the mean) associates with a >50% reduction in MACE risk, potentially via reduced arterial inflammation. These data raise the possibility that enhancing NBResilience may decrease the burden of cardiovascular disease.
Entities:
Keywords:
bone marrow; cardiovascular diseases; crime; income; positron emission tomography
Authors: Michael T Osborne; Azar Radfar; Malek Z O Hassan; Shady Abohashem; Blake Oberfeld; Tomas Patrich; Brian Tung; Ying Wang; Amorina Ishai; James A Scott; Lisa M Shin; Zahi A Fayad; Karestan C Koenen; Sanjay Rajagopalan; Roger K Pitman; Ahmed Tawakol Journal: Eur Heart J Date: 2020-02-01 Impact factor: 29.983
Authors: William M Schultz; Heval M Kelli; John C Lisko; Tina Varghese; Jia Shen; Pratik Sandesara; Arshed A Quyyumi; Herman A Taylor; Martha Gulati; John G Harold; Jennifer H Mieres; Keith C Ferdinand; George A Mensah; Laurence S Sperling Journal: Circulation Date: 2018-05-15 Impact factor: 29.690
Authors: Amparo L Figueroa; Amr Abdelbaky; Quynh A Truong; Erin Corsini; Megan H MacNabb; Zachary R Lavender; Meredith A Lawler; Steven K Grinspoon; Thomas J Brady; Khurram Nasir; Udo Hoffmann; Ahmed Tawakol Journal: JACC Cardiovasc Imaging Date: 2013-10-23
Authors: Hamed Emami; Parmanand Singh; Megan MacNabb; Esad Vucic; Zachary Lavender; James H F Rudd; Zahi A Fayad; Joshua Lehrer-Graiwer; Magnus Korsgren; Amparo L Figueroa; Jill Fredrickson; Barry Rubin; Udo Hoffmann; Quynh A Truong; James K Min; Amos Baruch; Khurram Nasir; Matthias Nahrendorf; Ahmed Tawakol Journal: JACC Cardiovasc Imaging Date: 2015-01-07
Authors: Jaana I Halonen; Anna L Hansell; John Gulliver; David Morley; Marta Blangiardo; Daniela Fecht; Mireille B Toledano; Sean D Beevers; Hugh Ross Anderson; Frank J Kelly; Cathryn Tonne Journal: Eur Heart J Date: 2015-06-23 Impact factor: 29.983
Authors: Wiktoria Wojciechowska; Andrzej Januszewicz; Tomasz Drożdż; Marta Rojek; Justyna Bączalska; Michał Terlecki; Karol Kurasz; Agnieszka Olszanecka; Mikołaj Smólski; Aleksander Prejbisz; Piotr Dobrowolski; Tomasz Grodzicki; Tomasz Hryniewiecki; Reinhold Kreutz; Marek Rajzer Journal: Hypertension Date: 2021-10-18 Impact factor: 10.190